30 Participants Needed

Imaging Techniques for Aortic Aneurysm

HF
MB
Overseen ByMauricia Buchanan, RN
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment ECG-gated MRA for aortic aneurysm?

Research shows that ECG-gated MR angiography improves the quality and reproducibility of aortic measurements, which can be crucial for accurate diagnosis and monitoring of aortic aneurysms. This technique provides clearer images by reducing the effects of heart motion, making it a reliable tool for assessing the heart and blood vessels.12345

Is ECG-gated MRA safe for humans?

Research indicates that magnetic resonance imaging (MRI), including ECG-gated MRA, is generally safe for humans, even those with cardiovascular devices, as long as specific conditions and recommendations are followed to minimize risks.15678

How does the imaging treatment for aortic aneurysm differ from other treatments?

The imaging treatment for aortic aneurysm using MRI, particularly contrast-enhanced MR angiography (CE-MRA), is unique because it is a noninvasive technique that combines conventional imaging with the acquisition of physiological parameters and 3D-angiography, providing detailed images of the aorta without the need for invasive procedures.2491011

What is the purpose of this trial?

The primary aim of this study is to establish the practicality of using two novel imaging modalities for the assessment of biomechanical properties of the aorta.

Research Team

HF

Houssam Farres, MD

Principal Investigator

Mayo Clinic

Eligibility Criteria

This trial is for adults over 18 who can consent and need aortic imaging or echocardiography, including those with abdominal aortic aneurysms (AAA) that are larger than normal. It's not for those without imaging needs, with IV contrast allergies or severe kidney issues, terminally ill patients, or those unable to undergo MRI.

Inclusion Criteria

I need special heart imaging but don't have an aortic aneurysm.
I need imaging for my heart or aorta for surgery planning or another reason, and I don't have an aortic aneurysm.
My aorta is at least 1.5 times its normal size.
See 1 more

Exclusion Criteria

You have a very serious illness, and doctors think you may have less than 6 months to live.
I cannot have IV contrast due to an allergy or severe kidney issues.
You cannot undergo a magnetic resonance imaging (MRI) scan.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-operative Work-up

Standard pre-operative work-up including MRA and ECHO, modified to include ECG-gating and 2-Dimensional speckle-tracking ultrasound

4 weeks

Treatment

Participants undergo either no surgery (surveillance), open surgery, or endovascular aneurysm repair (EVAR) with ECHO and ECG-gated MRA imaging

Varies by treatment group

Follow-up

Participants are monitored for 1 year to analyze the relationship between aortic wall properties and clinical outcomes

1 year

Treatment Details

Interventions

  • ECG-gated MRA
  • ECHO
Trial Overview The study tests the feasibility of using two new imaging methods—ECHO and ECG-gated MRA—to measure the biomechanical properties of healthy and aneurysmal aortas in various patients.
Participant Groups
3Treatment groups
Active Control
Group I: Surgery-EVARActive Control2 Interventions
EVAR with ECHO and ECG-gated MRA imaging.
Group II: Surgery-OpenActive Control2 Interventions
Open Surgery with ECHO and ECG-gated MRA imaging.
Group III: SurveillanceActive Control2 Interventions
No Surgery with ECHO and ECG-gated MRA imaging.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Findings from Research

ECG-gated contrast-enhanced MR angiography (CE-MRA) significantly improves image quality and measurement reproducibility of the ascending aorta compared to non-gated CE-MRA, as shown in a study of 53 patients.
The study found that non-gated CE-MRA had high variability in measurements, which could affect clinical decisions, while ECG gating reduced this variability, making it a better option for monitoring aortic conditions.
ECG-gated MR angiography provides better reproducibility for standard aortic measurements.Smith, LR., Darty, SN., Jenista, ER., et al.[2021]
The turbo spin-echo (TSE) method for magnetic resonance imaging (MRI) provides high-quality T2-weighted images of the cardiovascular system in a shorter time, making it efficient for diagnosing various heart conditions.
TSE imaging effectively reduces motion artifacts and enhances signal quality, aiding in the detection of tumors, clots, and other cardiovascular issues, thus proving to be a valuable alternative to traditional MRI methods.
Cardiac abnormalities: assessment with T2-weighted turbo spin-echo MR imaging with electrocardiogram gating at 0.5 T.Seelos, KC., von Smekal, A., Vahlensieck, M., et al.[2004]
Cardiac-gated MRI and contrast-enhanced magnetic resonance angiography (CE-MRA) are effective imaging techniques for assessing cardiac anatomy and tumors in dogs, providing detailed 2D and 3D images with short acquisition times under anesthesia.
Unlike contrast-enhanced CT angiography, cardiac MRI is safer as it does not involve ionizing radiation or iodinated contrast medium, making it a valuable alternative for specific cardiac evaluations.
Cardiac magnetic resonance imaging in normal dogs and two dogs with heart base tumor.Mai, W., Weisse, C., Sleeper, MM.[2019]

References

ECG-gated MR angiography provides better reproducibility for standard aortic measurements. [2021]
Cardiac abnormalities: assessment with T2-weighted turbo spin-echo MR imaging with electrocardiogram gating at 0.5 T. [2004]
Cardiac magnetic resonance imaging in normal dogs and two dogs with heart base tumor. [2019]
Primer on cardiac magnetic resonance imaging: how to perform the examination. [2019]
Doppler US gating of cardiac MR imaging. [2019]
Electrocardiographic Pad for Efficient Cardiac MR Gating. [2016]
Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document. [2023]
Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document. [2023]
Cardiac magnetic resonance imaging: the Massachusetts General Hospital experience. [2015]
10.United Statespubmed.ncbi.nlm.nih.gov
Imaging of aortic aneurysms and dissection: CT and MRI. [2022]
[MR imaging and MR angiography of the aorta]. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security